{"id":"https://openalex.org/W2093598997","doi":"https://doi.org/10.1016/j.amjcard.2012.05.031","title":"Efficacy and Safety of Eicosapentaenoic Acid Ethyl Ester (AMR101) Therapy in Statin-Treated Patients With Persistent High Triglycerides (from the ANCHOR Study)","display_name":"Efficacy and Safety of Eicosapentaenoic Acid Ethyl Ester (AMR101) Therapy in Statin-Treated Patients With Persistent High Triglycerides (from the ANCHOR Study)","publication_year":2012,"publication_date":"2012-07-20","ids":{"openalex":"https://openalex.org/W2093598997","doi":"https://doi.org/10.1016/j.amjcard.2012.05.031","mag":"2093598997","pmid":"https://pubmed.ncbi.nlm.nih.gov/22819432"},"language":"en","primary_location":{"id":"doi:10.1016/j.amjcard.2012.05.031","doi":"https://doi.org/10.1016/j.amjcard.2012.05.031","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.amjcard.2012.05.031","pdf_url":null,"source":{"id":"https://openalex.org/S185186944","display_name":"The American Journal of Cardiology","issn_l":"0002-9149","issn":["0002-9149","1879-1913"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The American Journal of Cardiology","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5052604218","display_name":"Christie Mitchell Ballantyne","orcid":"https://orcid.org/0000-0002-6432-1730","observed_orcids":["https://orcid.org/0000-0002-6432-1730"]},"institutions":[{"id":"https://openalex.org/I181547552","display_name":"Baylor College of Medicine","ror":"https://ror.org/02pttbw34","country_code":"US","type":"education","lineage":["https://openalex.org/I181547552","https://openalex.org/I2801539370"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Christie M. Ballantyne","raw_affiliation_strings":["Baylor College of Medicine and the Methodist DeBakey Heart and Vascular Center, Houston, Texas, USA. cmb@bcm.tmc.edu","Baylor College of Medicine and the Methodist DeBakey Heart and Vascular Center, Houston, Texas"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Baylor College of Medicine and the Methodist DeBakey Heart and Vascular Center, Houston, Texas, USA. cmb@bcm.tmc.edu","institution_ids":["https://openalex.org/I181547552"]},{"raw_affiliation_string":"Baylor College of Medicine and the Methodist DeBakey Heart and Vascular Center, Houston, Texas","institution_ids":["https://openalex.org/I181547552"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053191013","display_name":"Harold Edward Bays","orcid":"https://orcid.org/0000-0001-9912-1408","observed_orcids":["https://orcid.org/0000-0001-9912-1408"]},"institutions":[{"id":"https://openalex.org/I4210132010","display_name":"Louisville Metabolic and Atherosclerosis Research Center","ror":"https://ror.org/030y83r80","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210132010"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Harold E. Bays","raw_affiliation_strings":["Louisville Metabolic and Atherosclerosis Research Center, Louisville, Kentucky"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Louisville Metabolic and Atherosclerosis Research Center, Louisville, Kentucky","institution_ids":["https://openalex.org/I4210132010"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077848934","display_name":"John J.P. Kastelein","orcid":"https://orcid.org/0000-0003-2018-4532","observed_orcids":["https://orcid.org/0000-0003-2018-4532"]},"institutions":[{"id":"https://openalex.org/I2802928900","display_name":"Amsterdam UMC Location University of Amsterdam","ror":"https://ror.org/03t4gr691","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2802928900","https://openalex.org/I4210151833"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"John J. Kastelein","raw_affiliation_strings":["Academic Medical Center, Amsterdam, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Academic Medical Center, Amsterdam, The Netherlands","institution_ids":["https://openalex.org/I2802928900"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5106824193","display_name":"Evan A. Stein","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1296810283","display_name":"Medpace (United States)","ror":"https://ror.org/05mgcmd27","country_code":"US","type":"company","lineage":["https://openalex.org/I1296810283"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Evan Stein","raw_affiliation_strings":["Medpace, Cincinnati, Ohio"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medpace, Cincinnati, Ohio","institution_ids":["https://openalex.org/I1296810283"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039835160","display_name":"Jonathan L. Isaacsohn","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1296810283","display_name":"Medpace (United States)","ror":"https://ror.org/05mgcmd27","country_code":"US","type":"company","lineage":["https://openalex.org/I1296810283"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jonathan L. Isaacsohn","raw_affiliation_strings":["Medpace, Cincinnati, Ohio"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medpace, Cincinnati, Ohio","institution_ids":["https://openalex.org/I1296810283"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023941702","display_name":"Rene A. Braeckman","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210130338","display_name":"Amarin (United States)","ror":"https://ror.org/0353d6x38","country_code":"US","type":"company","lineage":["https://openalex.org/I4210113585","https://openalex.org/I4210130338"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Rene A. Braeckman","raw_affiliation_strings":["Amarin Pharma, Inc., Bedminster, New Jersey"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Amarin Pharma, Inc., Bedminster, New Jersey","institution_ids":["https://openalex.org/I4210130338"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5111956234","display_name":"Paresh N. Soni","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210130338","display_name":"Amarin (United States)","ror":"https://ror.org/0353d6x38","country_code":"US","type":"company","lineage":["https://openalex.org/I4210113585","https://openalex.org/I4210130338"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Paresh N. Soni","raw_affiliation_strings":["Amarin Pharma, Inc., Bedminster, New Jersey"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Amarin Pharma, Inc., Bedminster, New Jersey","institution_ids":["https://openalex.org/I4210130338"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":5,"corresponding_author_ids":["https://openalex.org/A5052604218"],"corresponding_institution_ids":["https://openalex.org/I181547552"],"apc_list":{"value":3380,"currency":"USD","value_usd":3380},"apc_paid":null,"fwci":24.1318,"has_fulltext":false,"cited_by_count":343,"citation_normalized_percentile":{"value":0.99847569,"is_in_top_1_percent":true,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":96,"max":100},"biblio":{"volume":"110","issue":"7","first_page":"984","last_page":"992"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10387","display_name":"Fatty Acid Research and Health","score":0.9868000149726868,"subfield":{"id":"https://openalex.org/subfields/2916","display_name":"Nutrition and Dietetics"},"field":{"id":"https://openalex.org/fields/29","display_name":"Nursing"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10387","display_name":"Fatty Acid Research and Health","score":0.9868000149726868,"subfield":{"id":"https://openalex.org/subfields/2916","display_name":"Nutrition and Dietetics"},"field":{"id":"https://openalex.org/fields/29","display_name":"Nursing"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10394","display_name":"Lipoproteins and Cardiovascular Health","score":0.01269999984651804,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T13430","display_name":"Lipid metabolism and disorders","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/eicosapentaenoic-acid-ethyl-ester","display_name":"eicosapentaenoic acid ethyl ester","score":0.925000011920929},{"id":"https://openalex.org/keywords/omega-3-fatty-acids","display_name":"omega-3 fatty acids","score":0.8999999761581421},{"id":"https://openalex.org/keywords/hypertriglyceridemia","display_name":"hypertriglyceridemia","score":0.902999997138977},{"id":"https://openalex.org/keywords/statin-treated-patients","display_name":"statin-treated patients","score":0.7879999876022339},{"id":"https://openalex.org/keywords/non-hdl-cholesterol","display_name":"non-HDL cholesterol","score":0.8289999961853027},{"id":"https://openalex.org/keywords/ldl-cholesterol","display_name":"LDL cholesterol","score":0.9819999933242798},{"id":"https://openalex.org/keywords/apolipoprotein-b","display_name":"apolipoprotein B","score":0.9810000061988831},{"id":"https://openalex.org/keywords/lipoprotein-associated-phospholipase-a2","display_name":"lipoprotein-associated phospholipase A2","score":0.9679999947547913},{"id":"https://openalex.org/keywords/high-sensitivity-c-reactive-protein","display_name":"high-sensitivity C-reactive protein","score":0.9150000214576721},{"id":"https://openalex.org/keywords/vldl-cholesterol","display_name":"VLDL cholesterol","score":0.8690000176429749},{"id":"https://openalex.org/keywords/drug-safety","display_name":"drug safety","score":0.4000000059604645}],"concepts":[{"id":"https://openalex.org/C2776091944","wikidata":"https://www.wikidata.org/wiki/Q409990","display_name":"Eicosapentaenoic acid","level":4,"score":0.7717437148094177},{"id":"https://openalex.org/C2776839432","wikidata":"https://www.wikidata.org/wiki/Q954845","display_name":"Statin","level":2,"score":0.6259317398071289},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5452258586883545},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4254959225654602},{"id":"https://openalex.org/C2910980524","wikidata":"https://www.wikidata.org/wiki/Q954845","display_name":"Hydroxymethylglutaryl-CoA Reductase Inhibitors","level":3,"score":0.41994667053222656},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3027108907699585},{"id":"https://openalex.org/C543025807","wikidata":"https://www.wikidata.org/wiki/Q61476","display_name":"Fatty acid","level":2,"score":0.2181812822818756},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.16685232520103455},{"id":"https://openalex.org/C178790620","wikidata":"https://www.wikidata.org/wiki/Q11351","display_name":"Organic chemistry","level":1,"score":0.13052982091903687},{"id":"https://openalex.org/C19038510","wikidata":"https://www.wikidata.org/wiki/Q2005087","display_name":"Polyunsaturated fatty acid","level":3,"score":0.04911983013153076}],"mesh":[{"descriptor_ui":"D002318","descriptor_name":"Cardiovascular Diseases","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D002318","descriptor_name":"Cardiovascular Diseases","qualifier_ui":"Q000209","qualifier_name":"etiology","is_major_topic":false},{"descriptor_ui":"D002318","descriptor_name":"Cardiovascular Diseases","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":true},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005500","descriptor_name":"Follow-Up Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010975","descriptor_name":"Platelet Aggregation Inhibitors","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D010975","descriptor_name":"Platelet Aggregation Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D012189","descriptor_name":"Retrospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013997","descriptor_name":"Time Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014280","descriptor_name":"Triglycerides","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":true},{"descriptor_ui":"D015118","descriptor_name":"Eicosapentaenoic Acid","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D015118","descriptor_name":"Eicosapentaenoic Acid","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D015118","descriptor_name":"Eicosapentaenoic Acid","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D015228","descriptor_name":"Hypertriglyceridemia","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D015228","descriptor_name":"Hypertriglyceridemia","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":false},{"descriptor_ui":"D015228","descriptor_name":"Hypertriglyceridemia","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019161","descriptor_name":"Hydroxymethylglutaryl-CoA Reductase Inhibitors","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D019161","descriptor_name":"Hydroxymethylglutaryl-CoA Reductase Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true}],"locations_count":4,"locations":[{"id":"doi:10.1016/j.amjcard.2012.05.031","doi":"https://doi.org/10.1016/j.amjcard.2012.05.031","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.amjcard.2012.05.031","pdf_url":null,"source":{"id":"https://openalex.org/S185186944","display_name":"The American Journal of Cardiology","issn_l":"0002-9149","issn":["0002-9149","1879-1913"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The American Journal of Cardiology","raw_type":"journal-article"},{"id":"pmid:22819432","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/22819432","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The American journal of cardiology","raw_type":"Clinical Trial, Phase III"},{"id":"pmh:oai:pure.amsterdamumc.nl:openaire_cris_publications/f0b1a023-74cb-4307-b47a-598f3db1e185","doi":null,"is_oa":false,"landing_page_url":"https://pure.amsterdamumc.nl/en/publications/f0b1a023-74cb-4307-b47a-598f3db1e185","pdf_url":null,"source":{"id":"https://openalex.org/S7407055222","display_name":"Pure Amsterdam UMC","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Ballantyne, C M, Bays, H E, Kastelein, J J, Stein, E, Isaacsohn, J L, Braeckman, R A & Soni, P N 2012, 'Efficacy and Safety of Eicosapentaenoic Acid Ethyl Ester (AMR101) Therapy in Statin-Treated Patients With Persistent High Triglycerides (from the ANCHOR Study)', American journal of cardiology, vol. 110, no. 7, pp. 984-992. https://doi.org/10.1016/j.amjcard.2012.05.031","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:amcpub:oai:pure.amc.nl:publications/f2a3588b-e469-4c36-817b-83854534381f","doi":null,"is_oa":false,"landing_page_url":"https://pure.amc.nl/en/publications/efficacy-and-safety-of-eicosapentaenoic-acid-ethyl-ester-amr101-therapy-in-statintreated-patients-with-persistent-high-triglycerides-from-the-anchor-study(f2a3588b-e469-4c36-817b-83854534381f).html","pdf_url":null,"source":{"id":"https://openalex.org/S4306401843","display_name":"Data Archiving and Networked Services (DANS)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1322597698","host_organization_name":"Royal Netherlands Academy of Arts and Sciences","host_organization_lineage":["https://openalex.org/I1322597698"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"American journal of cardiology, 110(7), 984 - 992. Elsevier Inc.","raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/randomized-controlled-trial","display_name":"Randomized Controlled Trial"},{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320306230","display_name":"American Heart Association","ror":"https://ror.org/013kjyp64"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":16,"referenced_works":["https://openalex.org/W100093211","https://openalex.org/W1508808956","https://openalex.org/W2036747551","https://openalex.org/W2066530607","https://openalex.org/W2100851898","https://openalex.org/W2106620061","https://openalex.org/W2132010550","https://openalex.org/W2132263678","https://openalex.org/W2142347023","https://openalex.org/W2145009492","https://openalex.org/W2164324917","https://openalex.org/W2165605025","https://openalex.org/W2198678228","https://openalex.org/W2477872031","https://openalex.org/W4230870013","https://openalex.org/W4285719527"],"related_works":["https://openalex.org/W2145009492","https://openalex.org/W2045859811","https://openalex.org/W2273958777","https://openalex.org/W112729673","https://openalex.org/W2135962533","https://openalex.org/W2021105673","https://openalex.org/W1965897168","https://openalex.org/W2182591237","https://openalex.org/W2104410864","https://openalex.org/W149359930"],"abstract_inverted_index":null,"counts_by_year":[{"year":2026,"cited_by_count":16},{"year":2025,"cited_by_count":7},{"year":2024,"cited_by_count":9},{"year":2023,"cited_by_count":28},{"year":2022,"cited_by_count":25},{"year":2021,"cited_by_count":23},{"year":2020,"cited_by_count":34},{"year":2019,"cited_by_count":34},{"year":2018,"cited_by_count":23},{"year":2017,"cited_by_count":22},{"year":2016,"cited_by_count":34},{"year":2015,"cited_by_count":23},{"year":2014,"cited_by_count":25},{"year":2013,"cited_by_count":35},{"year":2012,"cited_by_count":3}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}